BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 1505075)

  • 1. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
    Vadiei K; Siddik ZH; Khokhar AR; al-Baker S; Sampedro F; Perez-Soler R
    Cancer Chemother Pharmacol; 1992; 30(5):365-9. PubMed ID: 1505075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
    Khokhar AR; Wright K; Siddik ZH; Perez-Soler R
    Cancer Chemother Pharmacol; 1988; 22(3):223-7. PubMed ID: 3409456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes.
    Khokhar AR; al-Baker S; Krakoff IH; Perez-Soler R
    Cancer Chemother Pharmacol; 1989; 23(4):219-24. PubMed ID: 2647311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
    Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and anti-tumor activity of hydrophobic diammine and diaminocyclohexane platinum complexes entrapped in multilamellar vesicles.
    Khokhar AR; Al-Baker S; Perez-Soler R
    Anticancer Drug Des; 1988 Dec; 3(3):177-84. PubMed ID: 3207465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP)-a potential antitumour agent.
    Maclean DS; Khokhar AR; Tyle P; Perez-Soler R
    J Microencapsul; 2000; 17(3):307-22. PubMed ID: 10819419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R; Khokhar AR; Lopez-Berestein G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes.
    Mori A; Wu SP; Han I; Khokhar AR; Perez-Soler R; Huang L
    Cancer Chemother Pharmacol; 1996; 37(5):435-44. PubMed ID: 8599866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
    Verschraegen CF; Kumagai S; Davidson R; Feig B; Mansfield P; Lee SJ; Maclean DS; Hu W; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):549-55. PubMed ID: 14513369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
    Perez-Soler R; Lopez-Berestein G; Lautersztain J; al-Baker S; Francis K; Macias-Kiger D; Raber MN; Khokhar AR
    Cancer Res; 1990 Jul; 50(14):4254-9. PubMed ID: 2364384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in mouse resident peritoneal macrophages, Kupffer cells, and hepatocytes.
    Lautersztain J; Perez-Soler R; Turpin J; Khokhar AR; Siddik ZH; Schmidt K; Lopez-Berestein G
    Cancer Res; 1988 Mar; 48(5):1300-6. PubMed ID: 3342409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and biological studies on a series of lipid-soluble (trans-(R,R)- and -(S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes.
    Khokhar AR; al-Baker S; Brown T; Perez-Soler R
    J Med Chem; 1991 Jan; 34(1):325-9. PubMed ID: 1992134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesicles.
    Perez-Soler R; Yang LY; Drewinko B; Lauterzstain J; Khokhar AR
    Cancer Res; 1988 Aug; 48(16):4509-12. PubMed ID: 3396003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of toxicosis of liposome-encapsulated cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) in clinically normal cats.
    Fox LE; Toshach K; Calderwood-Mays M; Khokhar AR; Kubilis P; Perez-Soler R; MacEwen EG
    Am J Vet Res; 1999 Feb; 60(2):257-63. PubMed ID: 10048562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
    Perez-Soler R; Khokhar AR
    Cancer Res; 1992 Nov; 52(22):6341-7. PubMed ID: 1423280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use.
    Perez-Soler R; Francis K; al-Baker S; Pilkiewicz F; Khokhar AR
    J Microencapsul; 1994; 11(1):41-54. PubMed ID: 8138874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat.
    Los G; Mutsaers PH; Ruevekamp M; McVie JG
    Cancer Lett; 1990 May; 51(2):109-17. PubMed ID: 2344588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular accumulation and DNA damage induced by liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum+ ++(II) in LoVo and LoVo/PDD cells.
    Han I; Nguyen T; Yang LY; Khokhar AR; Perez-Soler R
    Anticancer Drugs; 1994 Feb; 5(1):64-8. PubMed ID: 8186432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
    Perez-Soler R; Lautersztain J; Stephens LC; Wright K; Khokhar AR
    Cancer Chemother Pharmacol; 1989; 24(1):1-8. PubMed ID: 2720887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.